-
Pharma & Biotech Industry Outlook - Nov. 2010 - Industry Outlook
Tuesday, November 9, 2010 - 6:03pm | 2720With 2010 coming to an end, the pharmaceutical industry continues to witness major challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant imbalance between new...
-
Pharma and Biotech Industry Outlook - Nov. 2010 - Industry Outlook
Tuesday, November 9, 2010 - 6:03pm | 2712With 2010 coming to an end, the pharmaceutical industry continues to witness major challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant imbalance between new...
-
OraSure Announces 2010 Third Quarter Financial Results: EPS of $0.01
Tuesday, November 9, 2010 - 5:03pm | 132OraSure Technologies, Inc. (Nasdaq: OSUR), a market leader in oral fluid diagnostics, today announced revenues of $19.0 million for the three months ended September 30, 2010, compared to $21.6 million recorded for the three months ended September 30, 2009. Revenues in the third quarter of 2009 were...
-
Collins Stewart Says Buy Alcon (ACL)
Tuesday, November 9, 2010 - 7:54am | 145Collins Stewart has a research note on Alcon, Inc. (NYSE: ACL), and it has a Buy rating on shares. It has a $180 price target on shares. In the research note, Collins Stewart writes, "Market share progression of Azarga in EU and launch of DuoTrav in Japan, (2) Launch progression of brimonidine 0....
-
U.S. DOJ Closes Its Investigation of Immucor
Monday, November 8, 2010 - 12:52pm | 91Immucor, Inc. (Nasdaq: BLUD) today announced that the United States Department of Justice, Antitrust Division, has informed Immucor that its investigation of the Company has been closed. As Immucor reported in April 2009, it had received a subpoena from the United States Department of Justice,...
-
Rochester Medical Reports Fourth Quarter and Year-End Results: EPS of $0.01
Thursday, November 4, 2010 - 4:22pm | 72Rochester Medical Corporation (Nasdaq: ROCM) today announced operating results for its fourth quarter and year ended September 30, 2010. The Company reported record sales of $11,121,000 for the current quarter compared to $9,009,000 for the fourth quarter of last year. It also reported quarterly...
-
Top Narrow Based Indexes For November 4 (SU, PAL, SVM)
Thursday, November 4, 2010 - 12:40pm | 209By 12:28 pm, the Dow Jones Industrial Average was up 191.41 points, or 1.71%, to 11,406.54, while the broader Standard & Poor's 500 index had gained 18.24 points, or 1.52%. The NASDAQ composite index rose 33.22 points, or 1.31%. Some of the narrow based indexes that are driving the market are...
-
RTI Biologics Announces 2010 Third Quarter Results
Thursday, November 4, 2010 - 8:17am | 231RTI Biologics Inc. (RTI) (NASDAQ: RTIX) reported operating results for the third quarter ended Sept. 30, 2010 as follows: Quarterly Highlights: Achieved quarterly revenues of $41.8 million, with gross margin of 48 percent. Achieved growth in the domestic sports medicine business of 20...
-
Uroplasty Soars On Earnings News (UPI)
Wednesday, November 3, 2010 - 1:13pm | 81Medical device company Uroplasty (NASDAQ: UPI) has jumped 14.74% to $5.06 during Wednesday's trading session after releasing its earnings results. The company reported a Q1 net loss of $929,000 or $0.06 per share compared to a loss of $1.37 million or $0.09 per share in the year ago period. Net...
-
Mid-Day Market Movers (RLD, UPI, MGIC, FSIN)
Wednesday, November 3, 2010 - 10:25am | 133RealD Inc (NYSE: RLD) jumped 21.48% to $26.98 at 10:18 am. RLD has reported better-than-expected Q2 results. Uroplasty Inc (NASDAQ: UPI) shares advanced 19.16% to $5.26. UPI posted a 9% y/y rise in its Q2 net sales. Magic Software Enterprises Ltd (NASDAQ: MGIC) shares surged 16.55% to $3.38. MGIC...
-
STAAR Surgical Reports Continued Double Digit Core Revenue Growth: Loss Per Share of $0.03
Tuesday, November 2, 2010 - 4:43pm | 100STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the third quarter ended October 1, 2010. Revenue for the period grew 6% to $13.2 million reflecting core product (IOLs and ICLs) revenue...
-
HAE Beats on EPS, Ups EPS Guidance - Analyst Blog
Tuesday, November 2, 2010 - 9:35am | 735Haemonetics Corporation (HAE) reported an EPS of 85 cents in the second quarter of fiscal 2011 compared with 69 cents in the year-ago quarter. However, after adjusting for certain one time items, EPS came in at 80 cents, surpassing the Zacks Consensus Estimate by 4 cents. The adjusted EPS was...
-
Zacks #5 Rank Additions for Tuesday - Tale of the Tape
Tuesday, November 2, 2010 - 9:35am | 343Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: Chiquita Brands Intl Inc (CQB) Comerica Inc (CMA) Delta Apparel Inc (DLA) Endologix Inc (ELGX) Faro Tech Inc (FARO) View the entire Zacks #5 Rank List. COMERICA INC (CMA): Free Stock Analysis Report CHIQUITA BR INT (CQB):...
-
3Q Should Be Low-Point For Haemonetics
Tuesday, November 2, 2010 - 7:44am | 154Haemonetics Corporation (NYSE: HAE) reported 2Q earnings that leads Morgan Keegan to believe that fiscal 3Q is expected to be the low-point in the company's sales cycle. In the report, Morgan Keegan writes "Haemonetics reported fiscal 2Q results that mirrored our expectations with sales that were...
-
Span-America Reports Fourth Quarter and Fiscal 2010 Results: EPS of $0.42
Monday, November 1, 2010 - 4:13pm | 59Span-America Medical Systems, Inc. (NASDAQ: SPAN) today reported its results for the fourth quarter and fiscal year ended October 2, 2010. The company reported fourth quarter 2010 sales of $13.8 million and net income of $1.2 million, or $0.42 per diluted share. Sales for fiscal year 2010 were $52....